Dow Down 0.17% Nasdaq Down 0.28%

Progenics Pharmaceuticals, Inc. (PGNX)

-NMS
5.19 0.06(1.14%) Sep 30, 4:00PM EDT
Prev Close:5.25
Open:5.00
Bid:4.15 x 200
Ask:5.36 x 400
1y Target Est:8.33
Beta:1.41
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.95 - 5.34
52wk Range:3.10 - 7.45
Volume:1,529,919
Avg Vol (3m):1,174,800
Market Cap:360.99M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 1.14%360.99M
DNDN223.82M
NKTR1.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-1.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback